ロード中...
The Association of Introducing a Faecal Calprotectin Testing Pathway for Suspected Inflammatory Bowel Disease in Primary Care and Time to Diagnosis or Treatment
BACKGROUND: Primary care faecal calprotectin (FC) was introduced in Leeds in 2014 to distinguish inflammatory bowel disease (IBD) from irritable bowel syndrome and with the hope that it may reduce time to IBD diagnosis and treatment. This study examines the association of FC with referral routes, ti...
保存先:
| 出版年: | Inflamm Intest Dis |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
S. Karger AG
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7706487/ https://ncbi.nlm.nih.gov/pubmed/33313071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000509907 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|